Flow Cytometry: Products, Technologies and Global Markets

Cell biology is currently the biggest revenue contributor to the life-science tools industry, accounting for approximately 30% of total sales.  It is expected to grow to a $15 billion market by 2015, increasing at a compound annual growth rate (CAGR) of 12.3% from its 2010 value of $8.5 billion.

Usha Nagavarapu | May 2011

The total global market for microbes and microbial products was worth more than $144 billion in 2010.  The 2011 market is projected to exceed $156 billion, and, by 2016, $259 billion, reflecting a 10.7% projected compound annual growth rate (CAGR) between 2011 and 2016.

Andrew McWilliams | Apr 2011

The life science tools market has shown steady growth over the last couple of years despite the economic downturn.  This market is currently valued at more than $42 billion and is projected to increase at compound annual growth rate (CAGR) of 13.6% to reach approximately $81 billion in 2016.

Marianna Tcherpakov | Apr 2011

The global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010. This market is expected to reach $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 forecast period to reach $14.1 billion in 2016.

Paul Evers | Mar 2011

In 2010, the total global market for biomarkers was an estimated $13.5 billion and is expected to grow to nearly $33.3 billion by the end of 2015 at a 5-year compound annual growth rate (CAGR) of 19.8%.

Jackson Highsmith | Mar 2011

The global market for transplantation products, devices, and pharmaceuticals was valued at nearly $54 billion in 2010 and is projected to grow at an 8.3% compound annual growth rate (CAGR) to reach $80 billion in 2015.

Peggy Lehr | Jan 2011